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The profound influence of the hosts genetic
makeup on resistance to infections has been
established in numerous animal studies (1,2) in
which disease phenotypes, environmental fac-
tors, and crosses can be controlled. Furthermore,
recent developments (e.g., use of gene knockout
or mutant and transgenic mice) allow genetic
analysis of complex traits involved in susceptibil-
ity or resistance to infectious pathogens (2,3). As
a result of these new developments, the Lsh/Ity/
Bcg gene was isolated on mouse chromosome 1,
which controls innate early susceptibility to
several  Mycobacterium species, as well as other
intracellular pathogens (e.g., Salmonella
Typhimurium,  Leishmania donovani) (2,4), and
was further identified and designated natural
resistance-associated macrophage protein 1
(Nramp1) (5). Involvement of a gene in an
experimental infection does not imply that
differences in susceptibility or resistance to that
infection in human populations can be accounted
for by polymorphisms in the human homologue
of this gene. Genetic epidemiology studies (6,7)
combine epidemiologic and genetic information
to identify the genes that influence substantially
the expression of human complex phenotypes,
such as infectious disease-related traits.
Epidemiologic information includes measured
risk factors that could influence the trait under
study (e.g., contamination by the infectious
agent, age). Genetic information is derived
from familial relationships between study
participants (collection of families) or from the
typing of genetic markers. Recent maps of the
human genome established on the basis of
highly polymorphic markers (8) are a
fundamental tool for studies involving genetic
markers, and two strategies can be used in this
context. The first, the candidate gene method,
is the typing of a few markers in a limited
number of chromosomal regions containing
genes related to the phenotype under study.
The second is a random search along the whole
genome (genomewide search) for chromosomal
regions that could be involved in the control of
the phenotype.
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The spread and clinical manifestations of an infection in human populations depend
on a variety of factors, among them host genetics. Familial linkage studies used in
genetic epidemiology to identify host genes test for nonrandom segregation of a trait
with a few candidate chromosomal regions or any regions in the genome (genomewide
search). When a clear major gene model can be inferred and reliable epidemiologic
information is collected (e.g., in schistosomiasis), parametric linkage studies are used.
When the genetic model cannot be defined (e.g., in leprosy and malaria), nonparametric
linkage studies (e.g., sibling-pair studies) are recommended. Once evidence of linkage
is obtained, the gene can be identified by polymorphisms strongly associated with the
trait. When the tested polymorphism is in strong linkage disequilibrium with the disease
allele or is the disease allele itself (e.g., in HIV infection and malaria), association
studies can directly identify the disease gene. Finally, the role of the detected
polymorphism in causing the trait is validated by functional studies.594 Emerging Infectious Diseases Vol. 4, No. 4, OctoberDecember 1998
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The genetic epidemiology of human infec-
tious diseases differs from the genetic study
of other complex phenotypes in three ways.
1) Environmental factors influencing the risk for
infection are generally known and when
accurately measured, can be included in the
analysis; 2) Choice of candidate genes is strongly
determined by the genes function and response
to the studied pathogen or by mouse-human
chromosome tests that exploit the identification
of murine resistance loci; and 3) Major genes
involved in the response to a given pathogen can
be identified by characterizing phenotypic
response to pathogen exposure, such as clinical
response, biologic response (intensity of infec-
tion), and immunologic response (levels of
antibodies or cytokines). The role of genetic
factors in the control of these phenotypic
responses is generally suggested by twin studies,
by strong ethnic differences, or by the great
variability of individual phenotypes within their
familial aggregation. Specific statistical methods
are used to identify these genetic factors and to
distinguish them from environmental factors
causing the familial resemblance. All these
statistical methods search for one or more genes
that influence the studied phenotype and are
classically divided into parametric and nonpara-
metric. Parametric, or model-based, methods
(segregation analysis and linkage analysis by the
classical lod-score method) require defining the
model and specifying the relationship between
the phenotype and factors (mainly a putative
gene and environmental covariates) that may
influence its expression. Nonparametric or
model-free methods (nonparametric linkage
analysis and association studies) study the
genetic factors influencing a phenotype without
specifying the model. Each method has advantages
and disadvantages; however, the two methods
complement each other. The choice of a design
for a particular study depends on several factors
related to the phenotype (e.g., nature, frequency),
population, accurate measurement of environ-
mental factors, and known genetic background.
Both methods have led to successful gene
localizations and identifications in the analysis
of several infectious disease phenotypes (9,10).
Parametric (Model-Based) Studies
Parametric studies require explicit specifica-
tion of the model, i.e., the definition of the
relationship between the observed phenotype
and the putative genotype. In a simple
monogenic disease due to a diallelic gene (D,d),
the model is specified by the frequency of the
deleterious allele (D for example) and the three
probabilities for a person to have the disease,
given the presence of genotype DD, Dd, or dd
(penetrances). For complex instances, such as
susceptibility/resistance, the susceptibility (or
the resistance) depends not only on a putative
genotype but also on environmental factors that
may influence exposure. In such cases, the
phenotype/genotype model includes, in addition
to the frequency of the deleterious allele, all the
parameters that describe and quantify the
relationship between susceptibility and the
relevant genetic and environmental factors. This
relationship can be mathematically expressed in
several ways, most recently regression methods
that define model parameters in terms of
regression coefficients. Furthermore, regression
methods could be used to analyze binary (11) as
well as quantitative (12) phenotypes. In
quantitative phenotypes, the effect of a genotype
is defined in terms of three different phenotypic
means depending on the genotypes of the study
participants. Parametric methods are based on
two kinds of complementary analyses, segrega-
tion analysis and linkage analysis by the
classical lod-score method (13). Both require
epidemiologic information (i.e., the measure of
the phenotype and of all relevant environmental
factors) for each family member. Linkage
analysis needs the typing of genetic markers.
Parametric Segregation Analysis
Segregation analysis is the first step in
determining from family data how a given
phenotype was inherited. Familial aggregation
of infection-related phenotypes can result from
genetic relationships, shared environment, and
cultural habits. The goal of segregation analysis
is to discriminate between these factors,
primarily to test for the existence of a single
gene, called a major gene. The major gene is not
the only gene involved in the expression of the
phenotype; rather, of all involved genes, this one
has an effect important enough to distinguish it
from the others. For a binary clinical phenotype
(affected/unaffected by the disease), this effect
can be expressed in terms of relative risks, e.g.,
the ratio of the probability for being infected
given a DD genotype to the probability of being
infected given a dd genotype. For a quantitative595 Vol. 4, No. 4, OctoberDecember 1998 Emerging Infectious Diseases
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phenotype, this effect is measured by the
proportion of the phenotypic variance explained
by the major gene (heritability due to the gene).
Primarily, segregation analysis uses maximum
likelihood methods to test whether the observed
familial distributions of the phenotype fit the
distributions expected under different hypoth-
eses of familial transmission (in particular the
segregation of a major gene). When evidence
indicates a major gene, segregation analysis
estimates the measurements for the phenotype/
genotype model, which are required for
parametric linkage analysis.
Parametric Linkage Analysis
Linkage analysis by the classical lod-score
method (13) confirms and locates the gene,
detected by segregation analysis (denoted as the
phenotype locus). Linkage analysis tests whether,
in families, the phenotype locus is transmitted
with genetic markers of known chromosomal
location. The lod score is a likelihood ratio testing
the hypothesis of linkage (against the hypothesis
of no linkage) for different genetic distances (or
recombination fractions) between the phenotype
locus and the marker locus (14). Classically,
two conclusions can be reached with a lod-score
analysis: 1) linkage between the two loci when
the lod score is above a given threshold, and
2) exclusion of linkage between the two loci
when the lod score is below a given threshold.
Linkage with the phenotype locus can be tested
marker by marker (two-point analysis) or by a set
of linked markers (multipoint analysis). In
linkage, as in segregation analysis, all inferences
for individual genotypes at the phenotype locus
are made from individual phenotypes and the
specified phenotype/genotype model; the lod-
score method is most powerful when this model is
well defined. A mispecification of the phenotype/
genotype model, however, can lead to both
inability to detect linkage (and therefore to false
exclusion of the region containing the phenotype
locus) and to a bias in the recombination fraction
estimate (i.e., the genetic distance) between the
phenotype locus and the marker locus (15).
Nevertheless, such a mispecification does not
affect the robustness of the method; i.e., it does
not lead to false conclusions in favor of linkage,
as long as only one phenotype/genotype model is
tested. Correction for multiple testing should
accompany the use of several phenotype/
genotype models. Similar problems occur when
several markers are tested, and guidelines have
been proposed to adapt lod-score thresholds to
the context of genomewide search (16). Another
problem arises when marker data are missing for
some family members. In this case, linkage
analysis also depends on marker allele frequencies;
mispecification of these frequencies can affect
both the power and robustness of the method.
Multiple marker testing and mispecification of
marker allele frequencies are also common
problems to the nonparametric methods.
Model-Based Studies and Infectious Diseases
Leprosy Studies
Several segregation analyses have been
performed in infectious diseases; some suggest
that a recessive major gene may play a role in
leprosy subtypes (lepromatous or nonlepromatous)
(17-19). A recessive major gene was also found to
influence leprosy regardless of the clinical defined
subtype, in pedigrees of large families from a
small Caribbean island (17); the frequency of the
deleterious allele was estimated to be 0.3 (9% of
homozygous persons predisposed to leprosy); by
age 60, the penetrance was approximately 0.6 for
predisposed homozygous, whereas it remained
below 0.02 for others. Lod-score analysis could
not find any linkage between this leprosy
susceptibility locus and five markers (including
HLA) that were typed in this population (20).
Malaria Studies
In malaria, segregation analyses have
focused on a quantitative phenotype measuring
the intensity of infection, i.e., parasitemia levels.
Although one study showed the role of a
recessive major gene controlling levels of
parasitemia (21), two subsequent studies found
evidence of a more complex genetic mechanism
(22,23). The discrepancies in these results can be
explained by several factors related to the host,
the parasite, and mosquito transmission.
However, all studies showed correlations
between siblings and between age and infection
(children becoming more often infected than
adults). Further genetic analyses such as sibling-
pair (sib-pair) study designs should focus on
infection in young children.
Schistosomiasis Studies
Model-based studies have been particularly
successful in finding susceptibility genes in596 Emerging Infectious Diseases Vol. 4, No. 4, OctoberDecember 1998
Synopses
schistosomiasis. Several reports indicated that
infection intensity was largely determined by the
susceptibility/resistance of infected persons (24).
In a Brazilian population, segregation analysis
showed that the intensity of infection by
Schistosoma mansoni was controlled by a major
gene (25). This gene, SM1, accounts for 66% of
the infection intensity variance that remains
after other covariate effects (water contact
levels, age, gender) have been taken into
account. Under this major gene model,
approximately 3% of the population is homozy-
gous and predisposed to very high infection
levels, 68% is homozygous resistant, and 29% is
heterozygous with intermediate levels of
resistance (Figure 1). Parametric linkage
analysis using the model estimated from
segregation analysis was used to locate the gene.
A genomewide search was carried out, and SM1
was mapped to human chromosome 5q31-q33, a
genetic region that contains several genes
encoding molecules that control T-lymphocyte
differentiation (26). More recently, a study in a
Senegalese population confirmed the presence of
a locus influencing S. mansoni infection levels on
chromosome 5q31-q33 (27). Furthermore, this
region has been linked with loci related to
immunoglobulin E (IgE) and eosinophilia
production, i.e., a locus regulating IgE levels
(28,29), a locus controlling bronchial
hyperresponsiveness in asthma (30), and a locus
involved in familial hypereosinophilia (31). This
genetic localization, together with observations
that human resistance to schistosomiasis is
regulated by lymphokines characteristic of Th2
subsets (32) and that resistant homozygotes
mount a Th0/2 response while susceptible
homozygotes exhibit a Th0/1 response against
schistosomes (V. Rodrigues, A. Dessein, unpub.
data), argues strongly that differences in human
susceptibility to schistosomiasis are influenced
by polymorphisms in a gene controlling T-
lymphocyte subset differentiation. In this
regard, a segregation analysis showed that
interleukin 5 (IL-5) levels are also under the
control of a major gene in the same Brazilian
population used in the study on infection
intensity  (33), raising the possibility that IL-5
might play a critical role in resistance, a view
consistent with the known role of IL-5 in the
defense against schistosome infections.
Another trait of interest in schistosomiasis is
the phenotype of severe hepatic fibrosis due to S.
mansoni infection for which the role of genetic
factors has been suggested. Segregation analysis
conducted in a Sudanese village found evidence
of major gene involvement in severe hepatic
periportal fibrosis (A. Dessein, L. Abel, unpub.
data). Whether this gene and SM1 are one and
the same is under investigation.
Nonparametric (Model-Free) Studies
Nonparametric or model-free studies (non-
parametric linkage analysis and association
studies) examine the genetic factors influencing
a phenotype without specifying the phenotype/
genotype model. These studies are strongly
recommended when little is known about the
relationship between the phenotype and a
putative gene as in the study of complex traits
(e.g., infectious disease-related traits) when
either no segregation analysis has been
performed or no clear major gene model can be
inferred from segregation analysis. Nonpara-
metric studies test whether or not the alleles of a
given marker are distributed at random in
persons having a certain phenotypic resem-
blance. Nonparametric linkage analyses study
the distribution of marker alleles inherited from
a same ancestor, i.e., alleles identical by descent
Figure 1. Distribution of the adjusted standardized
infection intensities by Schistosoma mansoni
predicted by the major gene model obtained from
segregation analysis and used for linkage analysis.
The frequency of allele A predisposing to high
infection levels was estimated at 0.16 (70% of aa, 27%
of Aa, and 3% of AA persons), and the three means
(corresponding to vertical lines) were -0.43, 0.78, and
3.96 for aa, Aa, and AA persons, respectively, with a
residual variance equal to 0.33.
aa persons
Aa persons
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(IBD), in persons from the same family (e.g.,
siblings), whereas association studies examine
the distribution of a given marker allele, e.g.,
HLA-DR2, in persons not from the same family.
Nonparametric Linkage Analysis
The most commonly used nonparametric
linkage analysis is the sib-pair method. Two
siblings can share 0, 1, or 2 parental IBD alleles
of any locus, and the respective proportions of
this sharing under random segregation are
simply 0.25, 0.5, and 0.25 (Figure 2). When the
phenotype under study is a clinical disease
(affected/unaffected), the method tests whether
affected sib-pairs share more parental alleles
than expected under random segregation. This
excess allele sharing can be tested by a simple
chi-square, in particular when all parental
marker data are known. Maximum likelihood
methods have also been developed to analyze
data from affected sib-pairs data, such as the
maximum likelihood score (34) and a maximum
likelihood binomial approach (35), and can lead
to more powerful tests. When the phenotypic
response under study is quantitative, the
method tests whether siblings with close
phenotype values share more IBD alleles than
siblings with more distant values. This is the
basis of the classical approach proposed by
Haseman and Elston (36), which regresses the
squared difference of the sib-pair phenotypic
values on the expected proportion of alleles
shared IBD by the sib-pair. Many recent studies
have used other methods not detailed here
(37-39).  Some of these methods are implemented
in popular packages, such as MAPMAKER/SIBS
(40), which also allow multipoint analysis of sib-
pair data. Sib-pair methods have the same
problems as parametric linkage analysis with
respect to missing parental marker data and
testing with multiple markers; in particular, the
number of comparisons made influences the
significance levels of the tests, and suspected
linkage should be confirmed by replication
studies. However, affected sib-pair methods
have been effective for several diseases, e.g.,
insulin-dependent diabetes mellitus (41,42), in
genomewide searches for human susceptibility
genes in a multifactorial phenotype.
Leprosy Studies
Sib-pair methods in infectious diseases have
focused on candidate regions and have not yet
resulted in published genome scans. In leprosy
studies using the HLA complex, sib-pair
analyses have shown a nonrandom segregation
of parental HLA haplotypes in sets of children
with tuberculoid leprosy and in siblings with
lepromatous leprosy, respectively (18,43,44).
However, the observed random segregation of
HLA haplotypes in all leprosy patients and in
healthy siblings in families with multiple cases of
leprosy argued against any involvement of HLA-
linked factors in susceptibility to leprosy (44,45).
The human gene NRAMP1 (46), homologue of
the mouse gene Nramp1, has provided an
excellent candidate gene for the study of
susceptibility to leprosy. A recent sib-pair study
in Vietnam has found linkage between leprosy
and NRAMP1 haplotypes consisting of six
intragenic variants of NRAMP1 and four
polymorphic flanking markers (47) and provided
the first evidence that NRAMP1 could be a
susceptibility locus for leprosy. Furthermore,
this study, combined with segregation analysis
performed in the same population (18),
suggested genetic heterogeneity according to the
ethnic origin of the families (Vietnamese or
Chinese), which may explain, at least in part, the
Figure 2. Principle of sib-pair analysis. Two siblings
can share 0, 1, or 2 parental marker alleles identical
by descent (IBD) at any locus with respective
probabilities 0.25, 0.5, and 0.25 under random
segregation.598 Emerging Infectious Diseases Vol. 4, No. 4, OctoberDecember 1998
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results of two previous reports that showed no
association between leprosy and distal chromo-
some 2q where NRAMP1 is located (48,49).
Overall, these studies suggest genetic control on
at least two levels: a first dependent on non
HLA-linked factors, among which NRAMP1
could play a role, and a second influenced by
HLA-linked genes.
Malaria Studies
Two sib-pair studies focusing on candidate
genes have been reported in malaria-related
phenotypes. In one (50), nonrandom segregation
of the MHC region was found in pairs of dizygous
twins with mild clinical malaria. In another (51),
the 5q31-q33 region, previously shown to be
linked to S. mansoni infection levels (26), may be
involved in the control of parasitemia due to
Plasmodium falciparum, although the sample
size was too small for definitive conclusion;
larger studies are ongoing.
Mycobacterium Studies
The recent demonstration that mutations in
the interferon g  receptor 1 (IFNgR1) gene cause
disseminated infection due to weakly pathogenic
mycobacteria (52,53) was first based on
homozygosity mapping (54), a nonparametric
linkage method, which locates a rare recessive
mutation in consanguineous families by search-
ing for chromosomal regions for which all
affected family members are homozygous IBD;
i.e., they have received two copies of the same
ancestral mutation. In consanguineous infected
children from two families, two groups located
the genetic defect on chromosome region 6q22-
q23 and identified mutations in the IFNgR1 gene
leading to the absence of expression of the
receptor at the cell surface (52,53). In vitro
experiments established the causative relation-
ship between the presence of two mutated
IFNgR1 alleles and impaired response to IFN  by
the cells of these patients (55). Although
inherited IFNgR1 deficiency was found in
additional families, IFNgR1 mutations were not
found in other families with infected patients
(J.L. Casanova, pers. comm.), which suggests
that other genetic defects may be involved.
Association Studies
Classic association studies are population-
based case-control studies that compare the
frequency of a given allele marker in unrelated
persons with the phenotype and controls without
the phenotype (6,7). G is the disease locus
influencing the trait, and M is the marker locus
under consideration; G is assumed to be diallelic
(D,d) with D being the deleterious allele, and M
has several alleles (M1, M2, ..., Mn). Association
studies examine the role of a particular allele of
M. As an example, M1 is said to be associated
with the disease under study if it is found at a
significantly higher or lower frequency in case-
patients than in controls by a simple 2 x 2
contingency table. The simplest explanation for
the association is that allele M1 is the deleterious
allele D itself. Another explanation is that M1 has
no direct effect on the phenotype but is in linkage
disequilibrium with allele D. Linkage disequilib-
rium means two conditions: 1) linkage between
locus M and locus G (generally close linkage) and
2) preferential association of allele M1 with allele
D; i.e., the DM1 haplotype is more frequent than
expected by the respective frequencies of D and
M1 (e.g., many present cases are due to one D
allele from an ancestor bearing the DM1
haplotype). Even very close linkage alone (only
the first condition is fulfilled) does not lead to
association, and therefore, the absence of
association does not exclude linkage. On the
basis of these two explanations, association
studies best use the candidate gene approach
when they consider markers that are either
within or in close linkage with a gene that is
related to the phenotypic response. A final
explanation for association is the existence of an
artifact due to population admixture. For
example, a case-control study conducted in a
mixture of two subpopulations of which one has a
higher disease prevalence and a higher M1
frequency than the second will show a positive
association of allele M1 with the disease. To avoid
population admixture, family-based association
methods have been developed (56), such as the
transmission disequilibrium test (TDT) (57). The
sampling unit in these methods consists of two
parents with an affected child; parental alleles
not transmitted to affected children are used as
controls. More specifically, the TDT considers
affected children of parents heterozygous for M1,
e.g., M1M2, and simply tests whether these
children have received M1 with a probability
different from 0.5, the value expected under
random segregation (Figure 3). The TDT is a
very efficient method of detecting the effect of
allele M1 when M1 is the deleterious allele D itself599 Vol. 4, No. 4, OctoberDecember 1998 Emerging Infectious Diseases
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(58). Under this hypothesis that the tested allele
M1 is the deleterious allele, TDT was more
powerful than even the sib-pair method in the
context of a genomewide search involving
500,000 diallelic polymorphisms (5 polymor-
phisms per gene for an assumed 100,000 genes)
(58). However, in the more common situation
where M1 is different from D, the power of TDT is
highly dependent on the respective frequencies
of M1 and D and the strength of the linkage
disequilibrium between M1 and D (59). These
results indicate that linkage methods are still
useful for identifying genes involved in
infectious diseases, at least until molecular
resources become available for full genomic
screening of human genes.
Leprosy Associations
Most reported associations between leprosy
and different HLA alleles could be due to
population admixture and statistical problems
(multiple testing); therefore, replication studies
are very important. In tuberculoid leprosy, the
most consistent associations were found with
HLA-DR2 (43,45). With HLA molecular typing, a
recent study (60) associated Indian tuberculoid
leprosy patients and alleles DRB1*1501,
DRB1*1502 (both DR2 alleles), and DRB1*1404,
which are characterized by arginines at position
13 or 70-71. Lepromatous leprosy was
associated with HLA-DR3 in several studies
(43,45). One report (44) analyzed the transmis-
sion of the parental DR3 allele to lepromatous
children by a method (similar to TDT)
presented several years later (57).
Malaria Associations
In malaria, population-based association
studies have been used to test the hypothesis
that certain genetic red cell defects, found more
frequently in malaria-endemic areas than in
nonendemic-disease areas, had a protective
effect against severe malaria (cerebral malaria,
severe anemia); the results supported the
hypothesis that persons with certain abnormal
hemoglobins (61) or glucose-6-phosphate-
deshydrogenase deficiency (62) had a reduced
risk of developing severe malaria. More recently,
a study in Gambia (63) showed that an HLA class
I antigen and an HLA class II haplotype were
independently associated with protection from
severe malaria when a two-stage strategy was
used to avoid the problem of multiple testing. In
the same population, persons homozygous for a
variant of the TNF-a  gene promoter, denoted as
TNF2, were found to have an increased risk
(independent of their HLA alleles) for cerebral
malaria (64). A recent work showing that TNF2
is a much stronger transcriptional activator than
the more common allele TNF1 (65) indicates that
TNF2 affects TNF-a expression and may be
directly responsible for the reported association
of TNF2 with cerebral malaria. These genetic
findings are consistent with immunologic
reports showing high TNF-a blood levels in
cerebral malaria. Although these genetic
polymorphisms (genetic defects of the red cell
HLA-TNF polymorphisms) have certainly played
a role in selection among populations exposed to
malaria infection (61,63), they cannot entirely
explain the large interindividual variable
responses to the parasite; likely only a minority
of genes influencing malaria resistance have
been identified (66). This view is supported by a
recent report that a coding polymorphism in the
intercellular adhesion molecule-1 (ICAM-1), a
molecule that affects adherence of infected red
blood cells to small vessel endothelium, is
associated with an increased susceptibility to
cerebral malaria (67).
Figure 3. Principle of the transmission disequilib-
rium test (TDT) for investigating association between
a disease and allele M1. The sample consists of x+y
families with one affected child and two parents. For
ease of presentation, we assume that only one parent
is heterozygous for M1 (e.g., M1M2), although the
second parent could be used for the test if he were
himself heterozygous for M1. There are x affected
children who have received allele M1 from their M1M2
parent and y who have received M2. The TDT statistic
is simply (x-y)2/(x+y), which is distributed as a chi-
square with  one degree of freedom.600 Emerging Infectious Diseases Vol. 4, No. 4, OctoberDecember 1998
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HIV Associations
A major advance in the involvement of host
factors in HIV-1 infection came when infection
status (seropositive/seronegative) was associ-
ated with the gene encoding the CC-chemokine
receptor 5 (CCR5), the coreceptor of macrophage-
tropic HIV-1 strains (68). Two persons exposed
many times to HIV-1, yet uninfected, were
shown to be homozygous for a defective CCR5
allele containing an internal 32 base-pair
deletion (D32) (69), and several large cohort
studies found HIV-1 infected patients not to be
CCR5D32 homozygous, whereas exposed HIV-1
seronegative persons did have the defective
allele (70-72). Subsequent reports showed that
this protection was not complete since some
CCR5D32 homozygous persons were found to be
HIV-1 infected (10). Furthermore, several
studies in HIV-1 infected persons found
CCR5D32 heterozygous status may protect
against disease progression (71,72), depending
on virus strain (73). However, it is clear that
CCR5D32 does not alone explain HIV-1 infection
status, especially in African populations where
D32 is absent (70,74), and the search for other
host genes involved in susceptibility/resistance
to HIV infection will be of major interest.
Conclusions
Recently developed genetic epidemiology
methods and dense human genetic maps,
together with the growing availability of
candidate genes, are essential for identifying
genes that influence human infectious diseases.
Nevertheless, investigating the role of genetic
factors in a given phenotypic response depends
on many different factors related to the
phenotype, population, accurate measurement
of environmental factors, and previous knowl-
edge; no unique optimal design can be applied for
most phenotypic responses related to infectious
agents. Among possible study designs, familial
linkage studies search for a chromosomal region
showing a nonrandom segregation with the
phenotype by either focusing on a few candidate
regions or using a genomewide search. The main
goals of the genome approach are to ensure that
all major loci involved in the control of a
phenotype are identified and to provide the
opportunity to discover new major genes (and
consequently physiopathologic pathways) in-
volved in phenotypic responses. Parametric
linkage studies are powerful when a clear major
gene model can be inferred from segregation
analysis. Nonparametric linkage studies are
strongly recommended when little is known
about the relationship between the studied
phenotype and a putative gene, and sib-pair
studies have led to successful gene localizations
in the analysis of several complex traits,
including infectious disease-related traits. Once
evidence for linkage is obtained, fine genetic and
physical mapping is performed to narrow down
the genetic interval. The next step is the search,
by molecular methods, of polymorphisms in
candidate genes located within the identified
interval. These candidate genes are selected
from gene databanks or are obtained by a
systematic characterization of the genes of the
region (positional cloning). On the other hand,
association studies performed with candidate
genes can directly identify the disease gene when
the tested polymorphism is in strong linkage
disequilibrium with the disease allele or is the
disease allele itself. Finally, evidence for an
association should be completed by functional
analysis, which will test whether the detected
polymorphism modifies the gene expression or
the gene product in a manner that can affect
susceptibility to the disease.
Progress in the genetic dissection of
infectious diseases will also come from the
integrated analysis of different phenotypic
responses (clinical response, intensity of infec-
tion, immunologic response), which can all
contribute to the pathologic process, as
illustrated in malaria and schistosomiasis
studies. The identification of host genes in
human infectious diseases will provide new
understanding of disease pathogenesis. How this
genetic information will modify our approach to
prevention and treatment of infectious diseases
cannot yet be fully appreciated. However, the
identification of susceptibility/resistance genes
in schistosomiasis, mycobacterial, and HIV
infections has already opened new avenues for
the screening of genetically predisposed persons
and the development of vaccines.
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